TELIX Pharmaceuticals Ltd Cash Flow Quality Index
TELIX Pharmaceuticals Ltd cash flow quality index. TELIX Pharmaceuticals Ltd (TLX) has a Cash Flow Quality Index of 3.04x as of June 2024. Operating cash flow of AU$35.45 Million exceeds net income of AU$11.68 Million, indicating high earnings quality where cash backs reported profits. Explore TLX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of TELIX Pharmaceuticals Ltd (2023–2024)
Cash flow quality index of TELIX Pharmaceuticals Ltd from 2023 to 2024. Historical Cash Flow Quality Index for TELIX Pharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See TELIX Pharmaceuticals Ltd net asset quality index to measure how much of total assets are equity-financed.
TELIX Pharmaceuticals Ltd Cash Flow Quality Index by Year (2023–2024)
TELIX Pharmaceuticals Ltd cash flow quality index by year from 2023 to 2024. Year-by-year earnings quality comparison for TELIX Pharmaceuticals Ltd. For the full cash flow conversion analysis, see TELIX Pharmaceuticals Ltd (TLX) cash conversion ratio.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | AU$43.03 Million | AU$49.92 Million | ▼ -81.2% |
| 2023 | 4.58x | AU$23.88 Million | AU$5.21 Million | — |